Dr. Camelia Quek is a CINSW Research Fellow at Melanoma Institute Australia and is appointed as an Honorary Senior Research Fellow at the University of Sydney. Dr Quek has training in both molecular biology and bioinformatics, where she originally did a first degree in molecular biology at the University of New South Wales before moving on to do a PhD in Neuroscience and Computational Biology at the University of Melbourne. Dr Quek has extensive experience in integrating cutting-edge techniques and sophisticated computation methods to solve clinically important questions that associate with strong clinical implementations. She is currently leading the Translational Bioinformatics and Data Analytics Program for cancer therapy studies that resulted in several key publications (e.g. Cancer Cell and Nature Publishing Group Journals) in identifying molecular determinants of response and resistance in patients with advanced melanoma treated with targeted and immune-based therapies. In 2017, she was part of the Melanoma Institute Australia research team that won the CINSW Premier’s Awards for Outstanding Cancer Research. In 2022, she was awarded the prestigious CINSW Wildfire Highly Cited Publication Award  for her co-first author paper published in Cancer Cell. Her current research interests are: (1) Biomarkers of response and resistance to cancer therapies, (2) Single-cell multi-omics to understand treatment and progression, and (3) Spatial imaging to dissect key cellular interactions and novel drug targets.